Instil Bio Discontinues ITIL-168 Cancer Trials, Layoffs 60% Of Its Employees
Instil Bio Inc (NASDAQ:TIL) announced a reprioritization of its clinical programs to focus on developing its CoStAR-TIL product candidates. The company…
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 160 companies set new 52-week lows.
What 6 Analyst Ratings Have To Say About Instil Bio
Analysts have provided the following ratings for Instil Bio (NASDAQ:TIL) within the last quarter: Bullish Somewhat Bullish Indifferent…
Instil Bio Q3 EPS $(0.43) Down From $(0.33) YoY
Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.43) per share. This is a 30.3 percent decrease over losses of $(0.33) per share from the same period last year.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.